Opening book details…
About this Medicine article
Can tocotrienol reduce time to the first serious adverse event during treatment with FOLFOXIRI for colorectal cancer? by Raunkilde, L; Hansen, T F; Jakobsen, A; Jensen, L H is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Raunkilde, L; Hansen, T F; Jakobsen, A; Jensen, L H
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2019
- Field
- Medicine (Health Sciences)
More by Raunkilde, L; Hansen, T F; Jakobsen, A; Jensen, L H
Browse all works by Raunkilde, L; Hansen, T F; Jakobsen, A; Jensen, L H